One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!

ABOS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.50%

Insider Buying (Last 12 Months): $39,999,997.50

Insider Selling (Last 12 Months): $382,384.76

Acumen Pharmaceuticals Insider Trading History Chart

Acumen Pharmaceuticals Share Price & Price History

^$3.17

▼ -0.02 (-0.63%)

As of 04/26/2024 11:03 AM ET

Days: 30 | 90 | 365

The Gold Grab of the Century

From Colonial Metals | Ad

When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.

That's why we have released our Free Precious Metals Investment Guide.

Acumen Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/19/2024	Daniel Joseph Oconnell	CEO	Sell	15,200	$3.47	$52,744.00	502,485
1/19/2024	Derek M Meisner	Insider	Sell	8,933	$3.48	$31,086.84	108,867
1/18/2024	Matt Zuga	CFO	Sell	4,242	$3.71	$15,737.82	211,445
1/18/2024	Russell Barton	COO	Sell	2,833	$3.73	$10,567.09	96,867
8/17/2023	Jeffrey L. Ives	Director	Sell	41,949	$6.49	$272,249.01
7/21/2023	Ra Capital Management, L.P.	Director	Buy	5,161,290	$7.75	$39,999,997.50	13,043,179
7/6/2021	John A. Stalfort, III	Director	Buy	35,000	$16.00	$560,000.00
7/6/2021	Paul B. Manning	Major Shareholder	Buy	312,500	$16.00	$5,000,000.00

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

SEC Filings (Institutional Ownership Changes) for Acumen Pharmaceuticals (NASDAQ:ABOS)

71.01% of Acumen Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Acumen Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/23/2024	Chicago Partners Investment Group LLC	18,315	$70K	0.0%	+34.9%	0.032%
2/15/2024	Parkman Healthcare Partners LLC	603,497	$2.32M	0.3%	+20.7%	1.042%
2/9/2024	Franklin Resources Inc.	3,358,809	$12.90M	0.0%	+18.3%	5.800%
2/7/2024	Jump Financial LLC	103,000	$0.40M	0.0%	+203.8%	0.178%
12/7/2023	Hudson Bay Capital Management LP	525,000	$2.18M	0.0%	+32.9%	0.907%
12/6/2023	Citigroup Inc.	38,498	$0.16M	0.0%	+5,423.4%	0.066%
11/15/2023	RA Capital Management L.P.	14,932,063	$61.97M	1.2%	+52.8%	25.803%
11/15/2023	Rock Springs Capital Management LP	2,812,579	$11.67M	0.3%	N/A	4.860%
11/15/2023	Laurion Capital Management LP	1,895,023	$7.86M	0.0%	+57.1%	3.275%
11/14/2023	Schonfeld Strategic Advisors LLC	645,112	$2.68M	0.0%	N/A	1.115%
11/14/2023	Knollwood Investment Advisory LLC	1,628,510	$6.76M	3.2%	N/A	2.814%
11/13/2023	DekaBank Deutsche Girozentrale	40,000	$0.17M	0.0%	N/A	0.069%
11/8/2023	Pathstone Family Office LLC	478,790	$1.99M	0.0%	+2.5%	0.827%
11/7/2023	Jump Financial LLC	33,900	$0.14M	0.0%	N/A	0.059%
11/3/2023	Intrepid Financial Planning Group LLC	30,150	$0.13M	0.1%	+49.6%	0.052%
10/26/2023	Chicago Partners Investment Group LLC	13,579	$56K	0.0%	N/A	0.023%
9/21/2023	Baystate Wealth Management LLC	18,020	$87K	0.0%	N/A	0.031%
8/14/2023	Deep Track Capital LP	3,916,361	$18.84M	0.9%	-0.9%	6.768%
8/14/2023	Prelude Capital Management LLC	31,100	$0.15M	0.0%	N/A	0.076%
8/2/2023	Catalyst Financial Partners LLC	89,699	$0.43M	0.2%	N/A	0.219%
8/2/2023	Baystate Wealth Management LLC	18,020	$87K	0.0%	N/A	0.044%
7/27/2023	Pinnacle Associates Ltd.	18,020	$87K	0.0%	N/A	0.044%
5/16/2023	Great Point Partners LLC	1,051,267	$4.27M	0.8%	-5.8%	2.563%
5/15/2023	Commodore Capital LP	400,000	$1.62M	0.2%	-19.7%	0.975%
5/15/2023	Guardian Point Capital LP	130,000	$0.53M	0.4%	-56.7%	0.317%
5/3/2023	Jump Financial LLC	10,183	$41K	0.0%	-52.1%	0.025%
5/2/2023	Intrepid Financial Planning Group LLC	30,150	$0.12M	0.1%	+201.5%	0.073%
4/26/2023	Chicago Partners Investment Group LLC	12,332	$47K	0.0%	-34.0%	0.030%
2/14/2023	Moore Capital Management LP	27,578	$0.15M	0.0%	-93.5%	0.068%
2/14/2023	683 Capital Management LLC	31,246	$0.17M	0.0%	N/A	0.077%
2/14/2023	Driehaus Capital Management LLC	563,864	$3.05M	0.0%	-1.3%	1.392%
2/13/2023	Pathstone Family Office LLC	530,330	$2.86M	0.0%	+109.4%	1.309%
2/10/2023	Cheyne Capital Management UK LLP	55,829	$0.30M	0.5%	N/A	0.138%
2/9/2023	Chicago Partners Investment Group LLC	18,679	$0.11M	0.0%	+68.5%	0.046%
2/7/2023	WMS Partners LLC	98,301	$0.53M	0.1%	-45.4%	0.243%
2/2/2023	Intrepid Financial Planning Group LLC	10,000	$54K	0.0%	N/A	0.025%
2/1/2023	Bank of Montreal Can	58,400	$0.33M	0.0%	N/A	0.144%
11/15/2022	Pathstone Family Office LLC	253,270	$2.54M	0.0%	N/A	0.625%
11/15/2022	Perceptive Advisors LLC	400,000	$4.01M	0.1%	-21.3%	0.988%
11/15/2022	Endurant Capital Management LP	55,328	$0.56M	0.2%	N/A	0.137%
11/15/2022	Commodore Capital LP	1,100,000	$11.03M	1.8%	N/A	2.716%
11/14/2022	Point72 Asset Management L.P.	40,936	$0.41M	0.0%	N/A	0.101%
11/14/2022	Boothbay Fund Management LLC	62,580	$0.63M	0.0%	+391.7%	0.155%
11/14/2022	Moore Capital Management LP	422,902	$4.24M	0.1%	+18.0%	1.044%
11/3/2022	Barclays PLC	34,161	$0.34M	0.0%	+408.0%	0.084%
10/28/2022	Silverarc Capital Management LLC	420,000	$4.21M	1.4%	N/A	1.037%
8/16/2022	Woodline Partners LP	426,170	$2M	0.0%	-15.0%	1.052%
8/15/2022	Laurion Capital Management LP	1,206,548	$5.67M	0.1%	+83.7%	2.979%
8/13/2022	Virtu Financial LLC	26,204	$0.12M	0.0%	N/A	0.065%
5/17/2022	Great Point Partners LLC	928,282	$3.63M	0.9%	N/A	2.292%
5/16/2022	Deep Track Capital LP	2,599,098	$10.16M	0.7%	+34.5%	6.418%
5/13/2022	Fiduciary Group LLC	10,000	$31K	0.0%	N/A	0.025%
5/10/2022	WMS Partners LLC	181,068	$0.71M	0.1%	N/A	0.447%
5/6/2022	Los Angeles Capital Management LLC	56,592	$0.22M	0.0%	N/A	0.140%
5/5/2022	New York State Common Retirement Fund	23,981	$94K	0.0%	+337.5%	0.059%
4/21/2022	Strs Ohio	41,300	$0.16M	0.0%	+24.0%	0.102%
2/19/2022	Woodline Partners LP	480,681	$3.25M	0.0%	+2.5%	1.188%
2/14/2022	Deep Track Capital LP	1,933,040	$13.07M	0.9%	N/A	4.776%
2/8/2022	Northern Trust Corp	94,984	$0.64M	0.0%	+8.7%	0.235%
2/2/2022	New York State Common Retirement Fund	5,481	$37K	0.0%	N/A	0.014%
1/24/2022	Strs Ohio	33,300	$0.23M	0.0%	+1,413.6%	0.082%
11/16/2021	Janus Henderson Group PLC	860,181	$12.77M	0.0%	N/A	2.126%
11/16/2021	Laurion Capital Management LP	656,848	$9.76M	0.0%	N/A	1.623%
11/16/2021	Moore Capital Management LP	369,583	$5.49M	0.1%	N/A	0.913%
11/16/2021	BVF Inc. IL	289,663	$4.30M	0.2%	N/A	0.716%
11/15/2021	Pura Vida Investments LLC	75,000	$1.12M	0.0%	N/A	0.185%
11/15/2021	Rock Springs Capital Management LP	1,579,191	$23.47M	0.5%	N/A	3.902%
11/15/2021	Marshall Wace LLP	156,250	$2.32M	0.0%	N/A	0.386%
11/15/2021	RA Capital Management L.P.	9,770,773	$145.19M	2.0%	N/A	24.144%
11/15/2021	Franklin Resources Inc.	937,500	$13.93M	0.0%	N/A	2.317%
11/12/2021	Geode Capital Management LLC	107,806	$1.60M	0.0%	N/A	0.266%
11/10/2021	Goldman Sachs Group Inc.	63,635	$0.95M	0.0%	N/A	0.157%
11/9/2021	BlackRock Inc.	2,868,791	$42.63M	0.0%	N/A	7.089%
11/4/2021	Sands Capital Ventures LLC	3,417,075	$50.78M	7.7%	N/A	8.444%
11/4/2021	Deutsche Bank AG	5,518	$82K	0.0%	N/A	0.014%

Data available starting January 2016

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

Today's Range

Now: $3.17

$3.16

$3.21

50 Day Range

MA: $3.86

$3.13

$4.64

52 Week Range

Now: $3.17

$1.81

$11.31

Volume

17,356 shs

Average Volume

370,515 shs

Market Capitalization

$190.45 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.08

Who are the company insiders with the largest holdings of Acumen Pharmaceuticals?: Acumen Pharmaceuticals' top insider shareholders include:
Ra Capital Management, LP (Director)
Daniel Joseph Oconnell (CEO)
Matt Zuga (CFO)
Derek M Meisner (Insider)
Russell Barton (COO)
Jeffrey L Ives (Director)
Learn More about top insider investors at Acumen Pharmaceuticals.

The World's First "$20 Trillion Drug?"

From Behind the Markets | Ad

Get the name of the stock here >>>